KIAA0101 anticorps (Cy7)
Aperçu rapide pour KIAA0101 anticorps (Cy7) (ABIN737937)
Antigène
Voir toutes KIAA0101 (PAF) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain, Rat
-
Réactivité croisée (Details)
- PAF
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated PAF
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF(IHC-P) 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- KIAA0101 (PAF) (PCNA Clamp Associated Factor (PAF))
-
Autre désignation
- Paf
-
Sujet
-
Synonyms: 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine monohydrate, 2-Acetyl-1-hexadecyl-sn-glycero-3-phosphocholine, 3-sn-Phosphatidylcholine, 1-hexadecyl-2-acetyl, PAFC16.
Background: Azelaoyl PAF is a potent PPAR_ agonist which competes for the thiazolidinedione binding site.
-
Pathways
- Chromatin Binding
Antigène
-